drugset / Trial / NCT00151398
Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks.
Timeline
- Start
- 2005-10-06
- Primary completion
- 2008-03-15
- Completion
- 2008-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | 10 mg | — |
| Subject | Lecozotan | Small molecule | 2 mg | — |
| Subject | Lecozotan | Small molecule | 5 mg | — |
| Subject | Lecozotan | Small molecule | 10 mg | — |